Literature DB >> 7517305

The treatment of pain following photorefractive keratectomy.

P M Cherry1, M K Tutton, H Adhikary, D Banerjee, B Garston, J M Hayward, T Ramsell, J Tolia, M L Chipman, A Bell.   

Abstract

The most effective management of the pain that follows excimer laser photorefractive keratectomy (PRK) appears to be the use of topical nonsteroidal anti-inflammatory agents. A bandage contact lens for 2 days after photorefractive keratectomy is additive to pain relief. The helpfulness of patching was not confirmed. Surprisingly, drops of local anesthetic were not an efficacious means of managing the pain. This was possibly because they were not used frequently enough. The findings showed trends, but were not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517305

Source DB:  PubMed          Journal:  J Refract Corneal Surg        ISSN: 1081-0803


  4 in total

1.  Effect of Homatropine eye drops on pain after photorefractive keratectomy: A pilot study.

Authors:  Mahmoud Joshaghani; Hossein Nazari; Khalil Ghasemi Falavarjani; Siamak Shokrollahi; Mohammad Jafar Ghaempanah; Kaveh Abri Aghdam; Zahra Mirbolouk Jalali
Journal:  Saudi J Ophthalmol       Date:  2012-07-31

2.  Preoperative Topical Diclofenac and Ketorolac in Prevention of Pain and Discomfort Following Photorefractive Keratectomy: A Randomized Double-masked Placebo-controlled Clinical Trial.

Authors:  Hassan Razmju; Ahmadreza Khalilian; Alireza Peyman; Seyed-Hossein Abtahi; Mohammad-Ali Abtahi; Mojtaba Akbari; Leyli Sadri
Journal:  Int J Prev Med       Date:  2012-03

3.  Ocular pain and discomfort after advanced surface ablation: an ignored complaint.

Authors:  Eva M Sobas; Sebastián Videla; Miguel J Maldonado; Jose C Pastor
Journal:  Clin Ophthalmol       Date:  2015-09-04

4.  Comparison of the effect of cycloplegic versus NSAID eye drops on pain after photorefractive keratectomy.

Authors:  Kaveh Abri Aghdam; Hossein Aghaei; Siamak Shokrollahi; Mahmoud Joshaghani; Hossein Nazari; Masih Hashemi; Mohammad Jafar Ghaempanah
Journal:  J Curr Ophthalmol       Date:  2016-01-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.